BRDT (bromodomain testis-associated) is a testis-specific epigenetic reader protein that binds acetylated histone H4 at lysines 5 and 8 (H4K5ac and H4K8ac) 1, playing a critical role in male spermatogenesis. In pachytene spermatocytes and round spermatids, BRDT binds acetylated histones at gene promoters to facilitate activation of meiotic and post-meiotic genes at appropriate developmental stages 2. During post-meiotic spermatogenesis, BRDT participates in histone removal from DNA and functions as a splicing component involved in 3'-UTR truncation of specific mRNAs 2. BRDT cooperates with stage-specific transcription factors (including MYB, RFX, and ETS in spermatocytes) to regulate diverse genes essential for meiosis and spermiogenesis 2. Mutations in BRDT cause acephalic sperm and spermatogenic failure 3. Beyond its testis-specific role, BRDT is ectopically expressed in cancers including lung and ovarian cancers, where it promotes tumor growth through regulation of oncogenic genes like PLK1 and AURKC 45. BRDT demonstrates both redundant and distinct functions compared to the ubiquitous BRD4, including bromodomain-independent RNA polymerase II regulation 5, positioning it as a potential therapeutic target in cancer treatment.